| Literature DB >> 20819185 |
Michael J Eckrich1, Haydar Frangoul, Jennifer Knight, Claudio Mosse, Jennifer Domm.
Abstract
The development of PTLD is a rare severe adverse event following ASCT. We report on a child with DS who developed PTLD following autologous transplant for relapsed Hodgkin's disease. He was successfully treated with cyclophosphamide, prednisone and rituximab. We also present a comprehensive review of the literature of PTLD in pediatric patients following ASCT.Entities:
Mesh：
Substances：
Year: 2010 PMID： 20819185 DOI： 10.1111/j.1399-3046.2010.01382.x
Source DB: PubMed Journal: Pediatr Transplant ISSN： 1397-3142